The importance of hormone receptor analysis in osteosarcoma cells growth submitted to treatment with estrogen in association with thyroid hormone

Cell Biochemistry and Function

Volumn 26, Issue 1, 2008, Pages 107-110

  Saraiva, Patricia Pinto ^a,d   Teixeira, Silvania Silva ^b   Conde, Sandro José ^c   Nogueira, Célia Regina ^c  

^a UNIVERSIDADE DO SAGRADO CORAÇÃO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d Jardim Panorama   (Brazil)

Author keywords

Alkaline phosphatase; Bone; Estrogen; Hormone receptors; MG 63; RANKL; SaOs 2; Thyroid hormone

Indexed keywords

ALKALINE PHOSPHATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; LIOTHYRONINE; OSTEOCLAST DIFFERENTIATION FACTOR; THYROID HORMONE; THYROID HORMONE RECEPTOR;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DRUG EFFECT; HORMONE DETERMINATION; HORMONE METABOLISM; HUMAN; HUMAN CELL; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE, TUMOR; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; OSTEOSARCOMA; RECEPTORS, ESTROGEN; RECEPTORS, THYROID HORMONE; THYROID HORMONES;

EID: 38549092231     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1408     Document Type: Article

References (21)

1. Ruza E, Sotillo E, Sierrasesumaga L, Azcona C, Patino-Garcia A. Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Ialpha1 genes and their relationship with height in children with bone cancer. J Pediatr Hematol Oncol 2003; 25: 780-786.
2. Barwick KW, Huvos AG, Smith J. Primary osteogenic sarcoma of the vertebral column: a clinicopathologic correlation of ten patients. Cancer 1980; 46: 595-604.
3. Merimsky O, Issakov J, Schwartz I, et al. Lack of ErbB-2 oncogene product overexpression in soft tissue sarcomas. Acta Oncol 2002; 41: 366-368.
4. Winding B, Misander H, Hoegh-Andersens P, Brunner N, Foged NT. Estradiol enhances osteolytic lesions in mice inoculated with human estrogen receptor-negative MDA-231 breast cancer cells in vivo. Breast Cancer Res Treat 2003; 78: 205-216.
5. Bovenkerk S, Lanciloti N, Chandar N. Induction of p53 expression and function by estrogen in osteoblasts. Calcif Tissue Int 2003; 73: 274-280.
6. Guise TA. Molecular mechanism of osteolytic bone metastases. Cancer 2000; 88: 2892-2898.
7. Bassett JH, Williams GR. The molecular actions of thyroid hormone in bone. Trends Endocrinol Metab 2003; 14: 356-364.
8. Lajeunesse D. Effect of 17 beta-estradiol on the human osteosarcoma cell line MG-63. Bone Miner 1994; 24: 1-16.
9. Siddiqi A, Burrin JM, Wood DF, Monson JP. Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells. J Endocrinol 1998; 157: 453-461.
10. Fohr B, Sshulz A, Battmann A. Sex steroids and bone metabolism: comparison of in vitro effects of 17beta estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation. Exp Clin Endocrinol Diabetes 2000; 108: 414-423.
11. Cheung J, Mak YT, Papaioannou S, Evans BA, Fogelman I, Hampson G. Interlekin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. J Endocrinol 2003; 177: 423-433.
12. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS. Transcriptional profiling of estrogen regulated gene expression via estrogen receptor (ER) alpha or ER beta in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 2004; 145: 3473-3486.
13. Leeming DJ, Koizumi M, Byrjalsen I, Li B, Qvist P, Tanko LB. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients. Cancer Epidemiol Biomarkers Prev 2006; 15: 32-38.
14. Takahashi S. Evaluation of cancer induced bone diseases by bone metabolic marker. Clin Calcium 2006; 16: 49-58.
15. Heremans H, Billiau A, Cassiman JJ, Mulier JC, De Somer P. In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines. Oncology 1978; 35: 246-252.
16. Fogh J, Trempe G. Human Tumor Cell Lines in vitro: New Human Tumor Cell Lines. Plenum Press: New York, 1975; 115-159.
17. Shevde NK, Bendixen AC, Dienger KM, Pike JW. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 2000; 97: 7829-7834.
18. Siddiqi A, Burrin JM, Wood DF, Monson JP. Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells. J Endocrinol 1998; 157: 454-461.
19. Nikitovic D, Tsatsakis AM, Karamanos NK, Tzanakakis GN. The effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by two osteosarcoma cell lines depends on tyrosine kinase and the estrogen receptor density. Anticancer Res 2003; 23: 459-464.
20. Bland R. Steroid hormone receptor expression and action in bone. Clin Sci 2000; 98: 217-240.
21. Simsek G, Karter Y, Aydin S, Uzun H. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism. Chin J Physiol 2003; 46: 181-186.